Works matching DE "ZIPRASIDONE"

Results: 216

Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2014, v. 29, n. 1, p. 38, doi. 10.1002/hup.2366

By:

Roffeei, Siti Norsyuhada;
Reynolds, Gavin P.;
Zainal, Nor Zuraida;
Said, Mas Ayu;
Hatim, Ahmad;
Aida, Syarinaz Ahmad;
Mohamed, Zahurin

Publication type:

Article

Efficacy and metabolic influence of paliperidone ER, aripiprazole and ziprasidone to patients with first-episode schizophrenia through 52 weeks follow-up in China.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2012, v. 27, n. 6, p. 605, doi. 10.1002/hup.2270

By:

Zhang, Yinbo;
Dai, Guangzhi

Publication type:

Article

Early improvement on antipsychotic treatment as a predictor of subsequent response in schizophrenia: analyses from ziprasidone clinical studies.

Published in:

Human Psychopharmacology: Clinical & Experimental, 2011, v. 26, n. 4/5, p. 282, doi. 10.1002/hup.1200

By:

O'Gorman, Cedric;
Kapur, Shitij;
Kolluri, Sheela;
Kane, John

Publication type:

Article

Preparation and evaluation of ziprasidone-phospholipid complex from sustained-release pellet formulation with enhanced bioavailability and no food effect.

Published in:

Journal of Pharmacy & Pharmacology, 2016, v. 68, n. 2, p. 185, doi. 10.1111/jphp.12510

By:

Miao, Yanfei;
Chen, Guoguang;
Ren, Lili;
Ouyang, Pingkai

Publication type:

Article

Novel tricyclic[2,1- f]theophylline derivatives of LCAP with activity in mouse models of affective disorders.

Published in:

Journal of Pharmacy & Pharmacology, 2014, v. 66, n. 12, p. 1755, doi. 10.1111/jphp.12305

By:

Partyka, Anna;
Jarosz, Jakub;
Wasik, Anna;
Jastrzębska‐Więsek, Magdalena;
Zagórska, Agnieszka;
Pawłowski, Maciej;
Wesołowska, Anna

Publication type:

Article

Efficacy and Tolerance of Antipsychotics Used for the Treatment of Patients Newly Diagnosed with Schizophrenia: A Systematic Review and Meta-Analysis.

Published in:

Pharmacy, 2023, v. 11, n. 6, p. 175, doi. 10.3390/pharmacy11060175

By:

Sherzad Qadir, Zina;
Ball, Patrick Anthony;
Morrissey, Hana

Publication type:

Article

In-silico and in-vitro study reveals ziprasidone as a potential aromatase inhibitor against breast carcinoma.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43789-1

By:

Sahu, Ankita;
Ahmad, Shaban;
Imtiyaz, Khalid;
Kizhakkeppurath Kumaran, Ajeeshkumar;
Islam, Mojahidul;
Raza, Khalid;
Easwaran, Murugesh;
Kurukkan Kunnath, Asha;
Rizvi, Moshahid A.;
Verma, Saurabh

Publication type:

Article

In-silico and in-vitro study reveals ziprasidone as a potential aromatase inhibitor against breast carcinoma.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43789-1

By:

Sahu, Ankita;
Ahmad, Shaban;
Imtiyaz, Khalid;
Kizhakkeppurath Kumaran, Ajeeshkumar;
Islam, Mojahidul;
Raza, Khalid;
Easwaran, Murugesh;
Kurukkan Kunnath, Asha;
Rizvi, Moshahid A.;
Verma, Saurabh

Publication type:

Article

Inpatient prescribing patterns of long-acting injectables and their oral or short-acting injectable equivalent formulations.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1140969

By:

Yifei Liu;
Patterson, Mark E.;
Sahil, Suman;
Stoner, Steven C.

Publication type:

Article

Atypical antipsychotics attenuate MK801-induced social withdrawal and hyperlocomotion in the RHA rat model of schizophrenia-relevant features.

Published in:

Psychopharmacology, 2023, v. 240, n. 9, p. 1931, doi. 10.1007/s00213-023-06411-w

By:

Sampedro-Viana, Daniel;
Cañete, Toni;
Sanna, Francesco;
Oliveras, Ignasi;
Lavín, Valeria;
Torrecilla, Pilar;
Río-Álamos, Cristóbal;
Tapias-Espinosa, Carles;
Sánchez-González, Ana;
Tobeña, Adolf;
Fernández-Teruel, Alberto

Publication type:

Article

Antipsychotics and risk of QT prolongation: a pharmacovigilance study.

Published in:

Psychopharmacology, 2023, v. 240, n. 1, p. 199, doi. 10.1007/s00213-022-06293-4

By:

Bordet, Constance;
Garcia, Philippe;
Salvo, Francesco;
Touafchia, Anthony;
Galinier, Michel;
Sommet, Agnès;
Montastruc, François

Publication type:

Article

Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis.

Published in:

Psychopharmacology, 2018, v. 235, n. 1, p. 245, doi. 10.1007/s00213-017-4763-x

By:

Vázquez-Bourgon, Javier;
Pérez-Iglesias, Rocío;
Ortiz-García de la Foz, Víctor;
Suárez Pinilla, Paula;
Díaz Martínez, Álvaro;
Crespo-Facorro, Benedicto

Publication type:

Article

A neuroimaging study of emotion-cognition interaction in schizophrenia: the effect of ziprasidone treatment.

Published in:

Psychopharmacology, 2017, v. 234, n. 7, p. 1045, doi. 10.1007/s00213-017-4533-9

By:

Stip, Emmanuel;
Cherbal, Adel;
Luck, David;
Zhornitsky, Simon;
Bentaleb, Lahcen;
Lungu, Ovidiu

Publication type:

Article

Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 year.

Published in:

Psychopharmacology, 2014, v. 231, n. 2, p. 357, doi. 10.1007/s00213-013-3241-3

By:

Crespo-Facorro, Benedicto;
Ortiz-Garcia de la Foz, Victor;
Mata, Ignacio;
Ayesa-Arriola, Rosa;
Suarez-Pinilla, Paula;
Valdizan, Elsa;
Martinez-Garcia, Obdulia;
Pérez-Iglesias, Rocío

Publication type:

Article

Dopamine D occupancy of ziprasidone across a day: a within-subject PET study.

Published in:

Psychopharmacology, 2013, v. 228, n. 1, p. 43, doi. 10.1007/s00213-013-3012-1

By:

Suzuki, Takefumi;
Graff-Guerrero, Ariel;
Uchida, Hiroyuki;
Remington, Gary;
Caravaggio, Fernando;
Borlido, Carol;
Pollock, Bruce;
Mulsant, Benoit;
DeLuca, Vincenzo;
Ismail, Zahinoor;
Mamo, David

Publication type:

Article

Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia.

Published in:

Psychopharmacology, 2013, v. 225, n. 3, p. 627, doi. 10.1007/s00213-012-2850-6

By:

Ou, Jian-Jun;
Xu, Yi;
Chen, Hong-Hui;
Fan, Xiaoduo;
Gao, Keming;
Wang, Juan;
Guo, Xiao-Feng;
Wu, Ren-Rong;
Zhao, Jing-Ping

Publication type:

Article

QT Interval Prolongation Associated with Intramuscular Ziprasidone in Chinese Patients: A Case Report and a Comprehensive Literature Review with Meta-Analysis.

Published in:

2014

By:

Xian-Bin Li;
Yi-Lang Tang;
Wei Zheng;
Chuan-Yue Wang;
de Leon, Jose

Publication type:

Case Study

Successful Ziprasidone Monotherapy in a Case of Delusional Parasitosis: A One-Year Followup.

Published in:

Case Reports in Psychiatry, 2013, p. 1, doi. 10.1155/2013/913248

By:

De Berardis, Domenico;
Serroni, Nicola;
Marini, Stefano;
Rapini, Gabriella;
Valchera, Alessandro;
Fornaro, Michele;
Mazza, Monica;
Iasevoli, Felice;
Martinotti, Giovanni;
Di Giannantonio, Massimo

Publication type:

Article

Effects of several atypical antipsychotics closapine, sertindole or ziprasidone on hepatic antioxidant enzymes: Possible role in drug-induced liver dysfunction.

Published in:

Journal of Toxicology & Environmental Health: Part A, 2021, v. 84, n. 4, p. 173, doi. 10.1080/15287394.2020.1844827

By:

Platanić Arizanović, Lena;
Nikolić-Kokić, Aleksandra;
Brkljačić, Jelena;
Tatalović, Nikola;
Miler, Marko;
Oreščanin-Dušić, Zorana;
Vidonja Uzelac, Teodora;
Nikolić, Milan;
Milošević, Verica;
Blagojević, Duško;
Spasić, Snežana;
Miljević, Čedo

Publication type:

Article

Effects of antipsychotic drug administration on antioxidative defense enzymes in male rat kidney.

Published in:

Journal of Toxicology & Environmental Health: Part A, 2016, v. 79, n. 20, p. 905, doi. 10.1080/15287394.2016.1201706

By:

Nikolić-Kokić, Aleksandra;
Mijušković, Ana;
Tatalović, Nikola;
Nestorov, Jelena;
Miler, Marko;
Oreščanin-Dušić, Zorana;
Nikolić, Milan;
Milošević, Verica;
Blagojević, Duško;
Spasić, Mihajlo;
Miljević, Čedo

Publication type:

Article

Anti-leucine-rich glioma-inactivated 1 encephalitis with manic symptoms as the initial manifestation.

Published in:

2018

By:

Tu, Tsung-Han;
Chan, Yee-Lam E.;
Bai, Ya-Mei

Publication type:

Case Study

Transient, asymptomatic, fluctuating bradycardia with oral ziprasidone in an older woman.

Published in:

2014

By:

Menon, Vikas;
Ramamourthy, Parthasarathy;
Ayyanar, Sugaparaneetharan

Publication type:

Letter

Schizophrenia and retinitis pigmentosa: Are there mechanisms which blind insanity?

Published in:

Australian & New Zealand Journal of Psychiatry, 2013, v. 47, n. 1, p. 95, doi. 10.1177/0004867412455701

By:

Narayanaswamy, Janardhanan C;
Viswanath, Biju;
Bada Math, Suresh

Publication type:

Article

Ziprasidone induced symptomatic bradycardia: a case report.

Published in:

Australian & New Zealand Journal of Psychiatry, 2011, v. 45, n. 9, p. 789, doi. 10.3109/00048674.2011.585456

By:

Menon, Vikas;
Kattimani, Shivanand;
Ayyanar, Sugaparaneetharan

Publication type:

Article

Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: a network meta-analysis and regression.

Published in:

Psychological Medicine, 2022, v. 52, n. 15, p. 3508, doi. 10.1017/S0033291721000180

By:

Carnovale, Carla;
Lucenteforte, Ersilia;
Battini, Vera;
Mazhar, Faizan;
Fornili, Marco;
Invernizzi, Elena;
Mosini, Giulia;
Gringeri, Michele;
Capuano, Annalisa;
Scavone, Cristina;
Nobile, Maria;
Vantaggiato, Chiara;
Pisano, Simone;
Bravaccio, Carmela;
Radice, Sonia;
Clementi, Emilio;
Pozzi, Marco

Publication type:

Article

Efficacy and acceptability of second-generation antipsychotics with antidepressants in unipolar depression augmentation: a systematic review and network meta-analysis.

Published in:

Psychological Medicine, 2022, v. 52, n. 12, p. 2224, doi. 10.1017/S0033291722001246

By:

Yan, Yushun;
Yang, Xiao;
Wang, Min;
Chen, Boran;
Yin, Li;
Ma, Xiaohong

Publication type:

Article

The Effects of Ziprasidone, Clozapine and Haloperidol on Lipid Peroxidation in Human Plasma (in vitro): Comparison.

Published in:

Neurochemical Research, 2013, v. 38, n. 7, p. 1490, doi. 10.1007/s11064-013-1050-z

By:

Dietrich-Muszalska, Anna;
Kopka, Justyna;
Kwiatkowska, Anna

Publication type:

Article

FDA-Approved Drugs to Treat Schizophrenia.

Published in:: Journal of Psychosocial Nursing & Mental Health Services, 2022, v. 60, n. 12, p. 7, doi. 10.3928/02793695-20221026-79
Publication type:: Article

FDA-Approved Drugs to Treat Schizophrenia.

Published in:: Journal of Psychosocial Nursing & Mental Health Services, 2021, v. 59, n. 12, p. 5, doi. 10.3928/02793695-20211026-79
Publication type:: Article

Clip & Save: Drug Chart.

Published in:: Journal of Psychosocial Nursing & Mental Health Services, 2015, v. 53, n. 6, p. 13, doi. 10.3928/02793695-20150505-79
Publication type:: Article

Clip & Save: Drug Chart.

Published in:: Journal of Psychosocial Nursing & Mental Health Services, 2014, v. 52, n. 12, p. 35, doi. 10.3928/02793695-20141029-79
Publication type:: Article

FDA-APPROVED DRUGS TO TREAT SCHIZOPHRENIA.

Published in:: Journal of Psychosocial Nursing & Mental Health Services, 2013, v. 51, n. 12, p. 47, doi. 10.3928/02793695-20131106-79
Publication type:: Article

Clip & Save: Drug Chart.

Published in:: Journal of Psychosocial Nursing & Mental Health Services, 2013, v. 51, n. 6, p. 47, doi. 10.3928/02793695-20130514-79
Publication type:: Article

Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial.

Published in:: BMC Psychiatry, 2011, v. 11, n. 1, p. 145, doi. 10.1186/1471-244X-11-145
Publication type:: Article

Atypical Antipsychotic Drug Ziprasidone Protects against Rotenone-Induced Neurotoxicity: An In Vitro Study.

Published in:

Molecules, 2020, v. 25, n. 18, p. 4206, doi. 10.3390/molecules25184206

By:

Terada, Kazuki;
Murata, Ayumi;
Toki, Erina;
Goto, Shotaro;
Yamakawa, Hirofumi;
Setoguchi, Shuichi;
Watase, Daisuke;
Koga, Mitsuhisa;
Takata, Jiro;
Matsunaga, Kazuhisa;
Karube, Yoshiharu;
Caruso, Giuseppe;
Musso, Nicolò;
Fresta, Claudia Giuseppina

Publication type:

Article

Ziprasidone Induces Rabbit Atrium Arrhythmogenesis via Modification of Oxidative Stress and Sodium/Calcium Homeostasis.

Published in:

Biomedicines, 2022, v. 10, n. 5, p. 976, doi. 10.3390/biomedicines10050976

By:

Tai, Buh-Yuan;
Lu, Ming-Kun;
Yang, Hsiang-Yu;
Tsai, Chien-Sung;
Lin, Chih-Yuan

Publication type:

Article

Treatment of bipolar disorder: A focus on medication therapy for mania.

Published in:

Formulary, 2011, v. 46, n. 3, p. 82

By:

Williams, Kristal L.;
Ruekert, Laura;
Lum, Cheen

Publication type:

Article

Ziprasidone-induced hypersensitivity syndrome confirmed by reintroduction.

Published in:

International Journal of Dermatology, 2014, v. 53, n. 4, p. e267, doi. 10.1111/ijd.12246

By:

Kim, Mi Sun;
Kim, Seo Wan;
Han, Tae Young;
Son, Sook Ja;
Lee, June Hyunkyung;
Kim, Eui‐Joong

Publication type:

Article

Crystal structure of ziprasidone hydrochloride monohydrate, C21H22Cl2N4OS(H2O).

Published in:

Powder Diffraction, 2015, v. 30, n. 3, p. 192, doi. 10.1017/S0885715615000305

By:

Kaduk, James A.;
Zhong, Kai;
Gindhart, Amy M.;
Blanton, Thomas N.

Publication type:

Article

Polyphenols from Berries of Aronia melanocarpa Reduce the Plasma Lipid Peroxidation Induced by Ziprasidone.

Published in:

Schizophrenia Research & Treatment, 2014, p. 1, doi. 10.1155/2014/602390

By:

Dietrich-Muszalska, Anna;
Kopka, Justyna;
Kontek, Bogdan

Publication type:

Article

Clinical Practice Associated with a Switch from and to Ziprasidone during Routine Inpatient Treatment of Patients with Schizophrenia.

Published in:

Schizophrenia Research & Treatment, 2011, p. 1, doi. 10.1155/2011/317368

By:

Müller, Matthias J.

Publication type:

Article

Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines.

Published in:

Acta Psychiatrica Scandinavica, 2018, v. 138, n. 3, p. 196, doi. 10.1111/acps.12896

By:

Verdolini, N.;
Hidalgo‐Mazzei, D.;
Murru, A.;
Pacchiarotti, I.;
Samalin, L.;
Young, A. H.;
Vieta, E.;
Carvalho, A. F.

Publication type:

Article

Crushing deutetrabenazine for treatment of tardive dyskinesia in a patient with severe orofacial symptoms: A case report.

Published in:

American Journal of Health-System Pharmacy, 2020, v. 77, n. 18, p. 1477, doi. 10.1093/ajhp/zxaa205

By:

Wietholter, Jon P;
Sizemore, Jenna;
Piechowski, Kara

Publication type:

Article

Health-related quality of life in patients treated with atypical antipsychotics.

Published in:

Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2020, v. 42, n. 6, p. 599, doi. 10.1590/1516-4446-2019-0739

By:

de Almeida, Juliana L.;
de Figueiredo Zuppo, Isabella;
Castel, Saulo;
Reis, Edna A.;
de Oliveira, Helian N.;
Ruas, Cristina M.

Publication type:

Article

Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone.

Published in:

Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2011, v. 33, n. 1, p. 30

By:

Baldaçara, Leonardo;
Sanches, Marsal;
Cordeiro, Daniel Cruz;
Jackoswski, Andrea Parolin

Publication type:

Article

Adverse Drug Events Related to Ziprasidone: A Meta-analysis of Randomized, Placebo-Controlled Trials.

Published in:

Pharmacotherapy, 2011, v. 31, n. 9, p. 840, doi. 10.1592/phco.31.9.840

By:

Harrington, Catherine A.;
English, Clayton

Publication type:

Article

Involvement of Cholinergic System in Hyperactivity in Dopamine-Deficient Mice.

Published in:

Neuropsychopharmacology, 2015, v. 40, n. 5, p. 1141, doi. 10.1038/npp.2014.295

By:

Hagino, Yoko;
Kasai, Shinya;
Fujita, Masayo;
Setogawa, Susumu;
Yamaura, Hiroshi;
Yanagihara, Dai;
Hashimoto, Makoto;
Kobayashi, Kazuto;
Meltzer, Herbert Y;
Ikeda, Kazutaka

Publication type:

Article

Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia.

Published in:

Neuropsychopharmacology, 2011, v. 36, n. 3, p. 616, doi. 10.1038/npp.2010.193

By:

McClay, Joseph L.;
Adkins, Daniel E.;
Åberg, Karolina;
Bukszár, Jozsef;
Khachane, Amit N.;
Keefe, Richard S. E.;
Perkins, Diana O.;
McEvoy, Joseph P.;
Stroup, T. Scott;
Vann, Robert E.;
Beardsley, Patrick M.;
Lieberman, Jeffrey A.;
Sullivan, Patrick F.;
Van den Oord, Edwin J. C. G.

Publication type:

Article

SWITCHING TO ZIPRASIDONE IN THE CLINICAL PRACTICE SETTING: AN OPEN-LABEL STUDY.

Published in:

International Journal of Psychiatry in Medicine, 2013, v. 45, n. 2, p. 125, doi. 10.2190/PM.45.2.c

By:

GUTIÉRREZ FRAILE, MIGUEL;
DE LA GÁNDARA MARTÍN, JESÚS J.;
BOBES GARCÍA, JULIO

Publication type:

Article

Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: A randomized study.

Published in:

American Journal on Addictions, 2014, v. 23, n. 3, p. 308, doi. 10.1111/j.1521-0391.2014.12126.x

By:

Schnell, Thomas;
Koethe, Dagmar;
Krasnianski, Anna;
Gairing, Stefanie;
Schnell, Knut;
Daumann, Jörg;
Gouzoulis‐Mayfrank, Euphrosyne

Publication type:

Article